Teva Metoclopramide Tablets
Metoclopramide Tablets, USP, 5 mg may contain foreign tablets or capsules.
Moderate risk
Taking it may cause temporary or medically reversible health problems. Serious harm is unlikely.
FDA Class II recall · How risk is rated
What happened
Teva Pharmaceuticals USA, Inc. recalled 240,448 cartons of Metoclopramide Tablets, USP, 5 mg, in bottles of 100 or 500 tablets, due to the presence of foreign tablets or capsules. The recall began on September 29, 2026, and was added to the FDA's Enforcement Report on October 13, 2026.
Summary by Recall Canary from the FDA notice.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Affected if its NDC and lot code are listed under that product.
Metoclopramide Tablets, USP, 5 mg
- NDC
- 0093-2204-01
- 0093-2204-05
- Lot
- 8634085
- 8635085
- 8636085
- 8633085
Details
- Company began the recall
- Event ID
- 100013
- Company
- Teva Pharmaceuticals USA, Inc
- Hazard
- Foreign material
- Quantity recalled
- 240,448 cartons
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA
Listed on Recall Canary
